Breast Cancer News

The latest breast cancer and reconstruction news from trusted resources all over the web.

In terms of duration of treatment and cost, patients with early stage breast cancer may benefit from accelerated partial breast irradiation (APBI) with proton therapy versus whole breast...
Adding tomosynthesis to biennial digital mammography screening for women with dense breasts is likely to improve breast cancer detection at a reasonable cost relative to biennial mammography...
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints.
The uncontrolled growth of cancer cells arises from their ability to hijack the cell's normal growth program and checkpoints.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced that the U.S.
Discontinuation and nonadherence were higher among breast cancer patients taking brand name aromatase inhibitors (BAIs) vs generic AIs (GAIs), according to a new study published in the JNCI: Journal...
@mchrysopoulo you would definitely want to attend our webinar on 5 things start-up practices should know http://t.co/u4Lywii6Q8 - CureMD (CureMD) http://twitter.com/CureMD/status/527138153744715777
Ludwig Oxford researchers have discovered a key mechanism that governs how cells of the epithelia, the soft lining of inner body cavities, shift between a rigid, highly structured and immobile state...
A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast...
A study has found that radiation therapy for Wilms tumor, a rare form of childhood kidney cancer, could lead to a higher risk of future breast cancer.


The BRCA 1 and 2 gene mutations, and a handful of other (rarer) gene mutations, account for about 10% of all breast cancer cases. The abnormal genes affect about 1 in 400 people and can be inherited from either or both parents.

BRCA gene mutations increase the lifetime risk of breast cancer in women to between 50 and 87% (depending on the study). The lifetime risk of breast cancer in the general population is about 12%.

Due to the publicity BRCA has received in the media lately, most people think it only affects women. That's not true. Men can be affected too. Men carrying an abnormal BRCA gene have a 5-10% risk of getting breast cancer at some point in their lives. Unaffected men only have a 0.1% lifetime risk.
If you're considering breast reconstruction using your own tissue (a "flap" procedure), it's important to know that achieving the best results usually involves several stages and takes time.
It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other parts of the body, a process known as metastasis.
The Angelina Jolie Effect is Real and Measurable | The #BreastCancer Site Blog http://t.co/ixYNSAby06
Stroma cells are derived from connective tissue and may critically influence tumour growth. This knowledge is not new.
An international research collaboration led by UC San Francisco researchers has identified a genetic variant common in Latina women that protects against breast cancer.
A new study by researchers from the Stanford Cancer Institute finds genomic sequencing may be more helpful in identifying a woman's risk for breast cancer than previously estimated
Many patients think or are told they cannot have immediate breast reconstruction (reconstruction at the same time as mastectomy) because it will significantly delay chemotherapy. In reality, breast reconstruction very rarely interferes with chemotherapy.


Patients that have immediate reconstruction and need chemotherapy can start their treatments once they have healed from their surgery. This usually takes about 4 weeks. The healing time required before chemotherapy is about the same whether patients have mastectomy alone or mastectomy and reconstruction.
After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free...

Pages